We develop predictive biomarkers of superior accuracy for your drug in clinical trial or on the market. Effective patient stratification ensures success and accelerates time to market. We work in close cooperation with our partners on all aspects of your clinical trial to assure approval of companion diagnostics.
OakLabs' team of quantum physicists and lifescientists has unique expertise in artificial intelligence and machine learning. At OakLabs, we are leveraging excellence in developing predictive biomarkers to improve drug development outcomes. We are ISO 9001:2015 certified.
Who we work with―
Learn how we can reach new heights together―
We look forward to learning more about your goals and ideas. Contact.